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SUMMARY 
Several meahanisms of metabolite ahanneling have been 
disaovered in arginine and pyrimidine biosynthesis in 
Neurospora. In the aase of aarbamyl phosphate, a pyrimidine-
speaifia "pool" of this aompound is aatually bound to a 
nualeolar enzyme aggregate whiah both makes and uses this 
aompound. In the arginine pathway, another pool of aarbamyl 
phosphate appears to be made and used in mitoahondria, to 
whiah the pool is aonfined. Finally, the large pools of 
arginine and ornithine found in Neurospora appear to be 
storage pools whiah are not on the main Zine of anabolia 
reaations. These pools also remain untouahed by the aata-
bolia enzymes, arginase ctnd ornithine transaminase, beaause 
the enzymes are in the aytoplasm and the pools are sequestered 
in a membrane-bound vesiale. AlZ of these "spatial" ahanneZing 
meahanisms aoexist with the more familiar, "kinetia'i regu-
latory meahanisms, suah as feedbaak inhibition and repression, 
The integration of spatial and kinetia regulatory phenomena 
in the aases disaussed represents a fundamental and often 
overlooked aspeat of metabolia organization in euaaryotes, 
1. INTRODUCTION 
One of the more familiar observations in biology is that 
eucaryotic cells are bigger, they grow more slowly, and they 
are more complex structurally than procaryotic cells. In 
this discussion, I would like to explore the inter-
relation of these points as they pertain to the organization 
of metabolism. 
To orient the discussion, we may look at some long-
standing generalizations about eucaryotic cells. First, 
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the size of eucaryotic cells requires mechanmism by which 
high concentrations of metabolites are achieved only locally. 
In this way, the entire large cell need not be flooded with 
intermediates to sustain optimal metabolic rates. Recently, 
it has been accepted that enzyme juxtaposition on the mem-
branes, in aggregates, and in organelles might lead to 
adaptively high local metabolite concentrations (DAVIS 1972, 
FINK 1971, WAGNER et al. 1967, OAKS and BIDWELL 1970). 
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Figure 1. Carbamyl-P metabolism in E. coli. 
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A second generalization is that the lower growth rates 
of eucaryotic cells entails less reliance upon kinetic fine-
tuning by the familiar regulatory mechanisms than is seen in 
procaryotes . Cell structure and the existence of metabolic 
reserves come to play a greater role in metabolic stability 
of eucaryotic cells. One of the major points to be made 
below is that storage actually requires compartmentation if 
it is to coexist with feedback inhibition and repression. 
Compartmentation of stored metabolites, in turn, brings with 
it a new set of controls regulating metabolite passage 
across inter- and intracellular membranes (DAINTY 1968) in 
response to demand. 
These generalizations about cell size, growth rate and 
metabolism were formulated long ago in one form or another. 
Why did they decline in visibility for a substantial time 
in cell biology? There are two related reasons. First, the 
METABOLIC ORGANIZATION IN NEUROSPORA 
great discoveries in the area of bacterial enzyme regulation 
revealed sophisticated mechanisms by which metabolism could 
be organized within a relatively unstructured cytoplasm. 
Because enzyme regulation was phenomenologically similar in 
procaryotes and eucaryotes, the role of structure in eu-
caryotes became intuitively minimized. The second reason 
was that certain phenomena originally interpreted in terms 
of compartmentation were too complex or were explained too 
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Figure 2. Carbamyl~P metabolism in Ne urosp ora ara s s a . Two 
pools of carbamyl-P are indicated by subscripts. 
Carbamyl-Ppyr is bound to the ATCase-CPSase P 
enzyme aggregate; carbamyl-Par is confined in 
mitochondria. Feedback inhibiiion is indicated 
by dotted lines. 
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inferentially to be taken for granted, In fact, many early 
data on the control of metabolic flow conformed to the ex-
pectations of both "kinetic" and "structural" hypotheses. 
This recalls STADLER'S (1954) admonition that "when obser-
vations and interpretation are unconsciously combined, we 
risk confusing what we know with what we only think we know." 
Many, including ourselves, have accepted uncritically one or 
the other side of the "channeling" question. Subsequently 
we have been motivated to obtain operationally valid evidence 
for the role of structure in metabolism, using the arginine 
and pyrimidine pathways of Neuro spora. 
2. KINETICS AND CHANNELING IN CARBAMYL 
PHOSPHATE METABOLISM 
The metabolism of carbamyl phosphate (carbamyl-P in pro-
and eucaryotes has been reviewed many times (O'DONOVAN and 
NEUHARD 1970, JONES 1971, DAVIS 1972, TATIBANA and SHIGESADA 
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1972). A brief comparison of how it is organized in E. coli 
and Neurospora crassa, however, will reveal the role structur-
al features play in the latter case (see Figures 1 and 2). 
Carbamyl phosphate is required in pyrimidine and arginine 
metabolism . In pyrimidine synthesis, carbamyl-P is used 
with aspartate by aspartate transcarbamylase (ATCase) to 
make ureidosuccinate . In the arginine pathway, carbamyl-P 
is used with ornithine by ornithine transcarbamylase (OTCase) 
to make citrulline. The control of carbamyl-P synthesis and 
its distribution to the two pathways is accomplished by 
radically different means in E. coli and Neurospora. 
In E. coli, carbamyl-P is synthesized by one enzyme, 
carbamyl-P synthetase (CPSase), and two transcarbamylases 
compete for the resulting pool (Figure 1). A sophisticated 
set of controls of the various enzymes prevents this compe-
tition from being maladaptive (for review, see O'DONOVAN and 
NEUHARD 1970). At the level of enzyme activity (as opposed 
to enzyme synthesis) we have: (a) a potentially complete 
inhibition of CPSase by a pyrimidine end-product, uridine 
triphosphate; (b) a potentially complete inhibition of ATCase 
by another pyrimidine, cytidine triphosphate; (c) an acti-
vation of CPSase by ornithine, and a reversal, by ornithine, 
of the inhibition of CPSase imposed by uridine triphosphate; 
and finally (d) feedback inhibition of ornithine synthesis 
by excess arginine. 
The behavior of this system is complex, but economical in 
many conditions . Where both end-products must be synthesized 
by the cell, carbamyl-P is made and is used appropriately by 
both transcarbamylases. In an excess of both arginine and 
pyrimidine, both pathways and the synthesis of carbamyl-P 
will be shut down. In excess arginine, no ornithine will be 
available to sustain carbamyl-P consumption by OTCase, or to 
fully activate CPSase; the reduced carbamyl-P supply will 
flow entirely through ATCase. Finally, in excess pyrimidines, 
ATCase will be wholly inhibited and endogenous pyrimidine 
synthesis will cease. The simultaneous and potentially 
complete inhibition of CPSase will be transitory at worst; 
the resulting arginine starvation will relieve inhibition of 
ornithine synthesis. Ornithine, as it accumulates, will 
relieve the pyrimidine-inhibition of CPSase, and the carbamyl-
P which is then made will be used wholly by OTCase. In 
addition to this set of immediate controls, repression of the 
enzymes of both pathways by the end-products also takes place. 
This extraordinary control of a branch-point compound, 
whose efficiency is independent of any obvious role of cell 
structure, is clearly one of evolution's better products. 
But this does not mean that compartmentation of carbamyl-P 
metabolism in eucaryotes, as seen in Neurospora, is incidental. 
In fact 1 the role of cell structure in the carbamyl-P 
metabolism of eucaryotes is well enough understood to suggest 
that compartmentation is necessary for survival. 
Carbamyl-P metabolism in Neurospora (Figure 2) differs 
in many respects from that~n E. coli (for review, see DAVIS 
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1972). ~here are two CPSases, one serving the pyrimidine 
pathway (CPSase P) and one serving the arginine pathway 
(CPSase A). When either CPSase is eliminated by mutation, 
the organism has an absolute and specific requirement for 
a corresponding supplement, uridine or arginine (WILLIAMS 
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and DAVIS 1970). This, and other evidence (WILLIAMS et al. 
1971), show that there is a confinement of two carbamyl-P 
pools to their respective pathways. With regard to structure, 
CPSase Pis aggregated in a bifunctional protein with ATCase, 
the next enzyme of the pathway (WILLIAMS et al. 1970). More-
over, the aggregate is found in the nucleolus (BERNHARDT and 
DAVIS 1972). CPSase A, on the other hand,is found in mito-
chondria, where OTCase is also found (WEISS and DAVIS 1973, 
BERNHARDT and DAVIS 1972) . Of all the four enzymes--two 
CPSases and two transcarbamylases--only CPSase Pis feedback 
inhibitable (by uridine triphosphate). Furthermore, CPSase 
A is very unusual because it is the only arginine biosynthetic 
enzyme we know that is fully repressible (DAVIS, unpublished); 
all others have high basal levels. 
This picture can be understood easily if we consider 
again the problem of cell size and the need for suitable 
metabolite concentrations. The latter consideration applies 
both to catalytic efficiency and to feedback control. 
In the arginine pathway, we believe carbamyl-P is normal-
ly confined within the mitochondrion. The pool, if its concen-
tration i~ given in terms of total cell water, is only about 
2.5 x 10- M (WILLIAMS et al. 1971). If confined to the mito-
chondrial volume (13% of cell volume: HAWLEY and WAGNER 1967), 
however, carbamyl-P concentration is 2 x 10-5 Mor so, the 
order of magnitude of the Km of OTCase for carbamyl-P at 
neutral pH (DAVIS 1967). Not only does the confinement 
satisfy the substrate concentration requirement of OTCase, it 
prevents escape of carbamyl-P into the ATCase reaction, which 
even in conditions of pyrimidine excess, might use carbamyl-P. 
We may therefore conclude that carbamyl-P metabolism of the 
arginine pathway requires structure to economize on the amount 
of carbamyl-P required at steady state. In this connection, 
it is worth noting that an E . c ol i cell (about 0.5 cubic 
micron) would not even fit into a Neu r os p o r a mitochondrion 
(about 0.15 cubic micron). If E. coli can do without such 
subcellular structure, the volume of the mitochondrion, 
rather than its internal organization, may be its most impor-
tant contribution to carbamyl-P metabolism. In regard to 
control, it is of interest that CPSase A, in the mito-
chondrion, is not directly exposed to cytoplasmic levels of 
arginine. We wish to determine in our future work whether 
the feedback insensitivity of CPSase A is related to the 
possibility that arginine concentrations in mitochondria might 
be higher or lower than (i.e., not representative of) those 
accessible to arginyl-tRNA synthetase in the cytoplasm. If 
so, the unusually high degree of repressibility of CPSase A 
may compensate for the enzyme's feedback insensitivity. In 
the evolution of arginine-specific carbarnyl-P metabolism, 
therefore, an unusual complication of the control system 
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(segregation of enzyme and the relevant feedback effector 
pool) may have been encountered and overcome. 
In the pyrimidine pathway, a second means of achieving 
adequate local carbamyl-P concentration is seen. By aggre-
gation of CPSase and ATCase, carbamyl-P molecules can remain 
effectively bound to the enzyme between their formation and 
their use. Not only do we find the molarity of carbamyl-P 
of the pyrimidine path to be less than that of the aggregate 
(WILLIAMS et al. 1971), but in yeast, the purified aggregate 
has been shown to confine carbamyl-P as an enzyme-bound 
intermediate in vitro (LUE and KAPLAN 1970). Thus we do not 
believe the nuclear membrane is necessary, as the mito-
chondrial membrane is, in the confinement of carbamyl-P. The 
localization of the CPSase P-ATCase aggregate appears to be 
significant in control: the feedback inhibitable enzyme, 
CPSase P, by being in the nucleolus, is directly exposed to 
the supply of pyrimidine nucleoside triphosphates where they 
ar~ most rapidly used. Again, we see that catalytic ef-
ficiency is met by structural means, and, in this case, 
control is facilitated by location. 
3. STORAGE AND CONTROL IN THE ARGININE PATHWAY 
In E. coli, pools of intermediates in amino acid and 
nucleotide synthesis, as well as the pools of end products, 
are maintained at low levels. These levels obviously meet 
the concentration requirements of the enzymes which use them, 
and endproducts are found in the subsaturating range of feed-
back inhibition sites on allosteric enzymes. This translates 
to concentrations of 0.5 - 10 x 10- 4 Min cell water 
(TEMPEST et al. 1970). Catabolism of such compounds, if they 
are anabolic intermediates, is limited, since catabolic 
enzymes are neither induced nor very active at low substrate 
concentration. The striking result is that the pool size of 
a typical amino acid in logarithmically growing bacterial 
cells is adequate for only a few seconds of protein synthesis 
at maximal rates (AMES 1964). This highlights the fluency of 
the biosynthetic control systems, which must maintain the 
correspondence between supply and demand. 
Investigations with eucaryotes have revealed the 
presence of substantial pools of metabolic intermediates, 
including organic acids, amino acids and their precursors, 
nucleotide-derivatives, and many secondary compounds. In 
plants, the large vacuole appears to be a repository for 
many of these compounds (MACLENNAN et al. 1963, BIDWELL et al. 
1964, OAKS and BIDWELL 1970), but in animals and fungi, the 
metabolic or storage roles of these large pools was revealed 
mainly in tracer studies, if at all (COWIE and WALTON 1956, 
HALVORSON and COHEN 1958, MORTIMORE et al. 1972, PHANG et al. 
1971). There was for some time no direct evidence about the 
location of these pools in the cell. In particular, it was 
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not clear how these large pools were prevented from over-
whelming the usual control mechanisms or how they were 
withheld from catabolic reactions. 
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In Neurospora, we had long been troubled by the very 
large pools of arginine and its precursor, ornithine (8 and 
10 mM, respectively, in cell water). We asked first how the 
feedback inhibitable enzyme of the pathway of ornithine 
synthesis continued to function in the presence of this level 
of the endproduct, arginine. Second, we were perplexed that 
little or no catabolism of either arginine or ornithine took 
place, despite the presence of substantial amounts of the 
catabolic enzymes, arginase and ornithine transaminase 
(DAVIS et al. 1970). The endogenous pools appeared to be 
segregated in some way within the cell, even though exogenous 
ornithine and arginine could be shown to exert feedback 
inhibition and/or were readily catabolized (ABELSON and 
VOGEL 1955, DAVIS 1968). 
In the last three years, our group at the University of 
Michigan has attempted to unravel these paradoxes. In the 
courses of investigating enzyme localization, pool localiza-
tion and tracer kinetics, we feel we have uncovered the major 
structures and rules by which Neurospora governs arginine 
metabolism. 
Dr. Weiss and Dr. Cybis have shown by differential centri-
fugation of gently disrupted cells that most of the bio-
synthetic enzymes of the pathway are in mitochondria (WEISS 
and DAVIS 1973, CYBIS and DAVIS, unpublished). These include 
five enzymes: three leading to ornithine formation; CPSase A, 
and OTCase. Only the last two biosynthetic enzymes, arginino-
succinate synthetase and lyase are in the "soluble" (non-
organellar) fraction. The putrescine-forming enzyme, 
ornithine decarboxylase, and the two catabolic enzymes, 
arginase and ornithine transaminase, are also in the · 
"soluble" phase (see Figure 3). 
In the same sequence of experiments, Dr. Weiss was able 
to demonstrate that the majority of the large arginine and 
ornithine pools were sedimentable (WEISS 1973). More detailed 
work showed that these were associated with an osmotically 
sensitive organelle, which we call the "vesicle", and which 
also contains lysine and histidine (WEISS, unpublished). 
Controls excluded the possibility that the sedimentability of 
the pools was an artifact of fractionation. So far, there 
is no evidence that other amino acids are also associated 
with the vesicle in vivo, and some evidence that proline and 
citrulline are not (KARLIN and DAVIS, unpublished). We 
immediately felt that the vesicle could be a means by which 
the arginine and ornithine pools were segregated from 
catabolic enzymes, the sites of their induction, from feedback 
inhibition sites, and perhaps even from anabolic enzymes and 
protein synthesis. This of course would define these pools 
as "sideline", or reservoir pools; whatever their adaptive 
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role, we could ask empirically whether they were relatively 
inactive metabolically. 
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Figure 3. Arginine and proline metabolism in Neurospora 
(schematic), showing location of enzymes and 
small molecules. Open arrows (reactions 1 - 11) 
denote biosynthetic reactions; broken arrows 
(reactions 12 - 15) denote catabolic reactions; 
solid arrows denote membrane passage. The 
enzymes are: 1-4, early steps of ornithine 
synthesis; 4, OTCase; 6 and 7, argininosuccinate 
synthetase and lyase, respectively; 8, CPSase A; 
9, ornithine decarboxylase; 10, biosynthetic 
enzyme(s) of glutamic-y-semialdehyde synthesis; 
11, pyrroline-5-carboxylate reductase; 12, 
arginase; 13, urease; 14, ornithine trans-
aminase; 15, pyrroline-5-carboxylate oxidase. 
(Pyrroline-5-carboxylate is the stabler, cyclic 
form of glutamic-y-semialdehyde; it is both 
a proline intermediate and an arginine catabolite). 
Tracer studies by Dr. Subramanian, Ms. Karlin and 
Dr. Weiss were used to answer this question, as it turns out, 
in the affirmative (SUBRAMANIAN et al. 1973, KARLIN and DAVIS, 
unpublished). The hypothesis is that in vivo, the "cytosol" 
has less--perhaps much less--than 10% of the arginine and 
ornithine, the remainder being in the vesicle. The experi-
mental expectation is that if a tiny amount of very 
radioactive arginine or ornithine is added to growing cells, 
i~ ~11 initially enter the cytosol. There, the label will 
be used in reactions which are cytoprasmic before it · mixes 
with the large vesicular pool of the amino acid in question. 
Specific radioactivity studies of the initial products of 
utilization showed that indeed, labelled arginine bypassed the 
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endogenous arginine pool as it was used in protein synthesis. 
Likewise, exogenously added, labelled ornithine bypassed the 
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Figure 4. Behavior of exogenous 14c-arginine (tracer levels) 
as it enters Neurospora cells. Labelled arginine 
is indicated by dots. Abbreviations: ORN, 
ornithine; CIT, citrulline; ARG, arginine. 
endogenous ornithine pool as the former was used in synthesis 
of putrescine, glutamic semialdehyde, and citrulline (see 
Figure 3). In the initial moments of the experiments, the 
dilution of label showed that only three percent or less of 
the ornithine and arginine in the cell were mixing with the 
isotope entering the cell membrane. When the label was all 
absorbed from the medium in 2 to 8 minutes) we found that 
whatever isotope had not been used was now in an inactive 
pool, substantially withheld from most reactions. This 
remaining label had, we concluded, become side-lined by 
uptake into the vesicle. The behavior of arginine is shown 
diagramatically in Figure 4. 
A closer look at ornithine yielded some surprises. It 
was expected that conversion of exogenous 14c-ornithine to 
putrescine would be efficient since ornithine decarboxylase 
was a cytoplasmic, anabolic enzyme. But the labelled orni-
thine also found its way into mitochondria where it was used 
with only moderate dilution for citrulline and arginine syn-
thesis (KARLIN and DAVIS, unpublished). In vivo, of course, 
all ornithine originates within the mitochondria, part of it 
escaping into the cytoplasm and the vesicle. Second, labeled 
ornithine was used almost equally well by cytoplasmic ornithine 
transaminase, a catabolic enzyme. This sugge·sted that the 
cytoplasmic pool was transiently elevated by uptake of the 
small amount of labelled ornithine or, if not, that a small 
amount of cytoplasmic ornithine is always being lost by 
catabolism. [This possibility had emerged much earlier from 
the leakiness of proline mutants, in which ornithine catab-
olism is an alternate pathway of proline synthesis (DAVIS 
1968)]. It appears then that the vesicle, by absorbing orni-
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thine from the cytoplasm, is a major factor in preventing 
wasteful catabolism under conditions of normal growth, and 
the reason that the proline and arginine pathways are almost 
completely separate metabolically. 
The behavior of arginine is simpler. Tracer levels of 
exogenous arginine are either incorporated into protein or 
are absorbed into the vesicle (Figure 4). Arginase, though 
cytoplasmic, does not catabolize significant amounts of 
arginine in the cytoplasm unless arginine is presented to 
the cell in high concentration. This suggests that there is 
a substrate concentration threshold which must be reached 
before arginase will become catalytically active. While this 
is yet to be proven directly, it is clear that the vesicle 
has the function of poising the cytoplasmic arginine concen-
tration between the threshold of arginase, estimated at about 
5 x 10- 4 M, and the Km of arginyl-tRNA synthetase, which is 
2 x 10 -5 M (NAZARIO i967). 
Finally, Dr. Weiss has shown that arginine is catabolized 
only when it is in the external medium and entering the cell 
rapidly through the cell membrane (WEISS, unpublished). It 
appears that, due to a failure of the vesicle to keep up with 
the cell membrane in the absorption of arginine, the arginine 
concentration in the cytoplasm rises and satisfies the 
substrate concentration requirement of arginase. Interest-
ingly, almost the moment arginine stops entering the cell, 
catabolism stops, apparently because the vesicle absorbs or 
has absorbed the bulk of arginine already in the cell. With 
an arginine-requiring auxotroph, Dr. Weiss showed that until 
intracellular arginine is gone, the vesicle releases arginine 
fast enough to sustain a maximal rate of protein synthesis, 
but slow enough to prevent catabolism completely. The 
vesicle therefore is a means of conserving a large pool of 
arginine for anabolic use after the environment stops pro-
viding it. This is strikingly different from E. coli, 
whose arginine auxotrophs begin starving a few minutes after 
arginine disappears from the medium. 
4. SIGNIFICANCE 
To summarize, I will return to our major initial points. 
First, cells of eucaryotes have become bigger not by magni-
fying the size of the unstructured procaryotic cell. Instead, 
eucaryotes have developed structural means of confining 
metabolites so they are in high concentration where they are 
needed. They have exploited, more than procaryotes have, the 
"molecular compartmentation" possibilities of the organized 
enzyme aggregate (FINK 1971, LUE and KAPLAN 1970), as ex-
emplified in our work by the complex of CPSase P and ATCase. 
Another mechanism, as seen in the mitochondrial confinement 
of carbamyl-P for the arginine pathway, conserves energy, 
maintains optimal carbamyl-P concentration, and isolates the 
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pathways competing for this compound. Whatever the course 
upon which these complex changes evolved, the present state 
is efficient both in terms of catalytic rates and regulation. 
Whether or not these changes became necessary--and any 
evolutionist will conclude they did if they exist-- they are 
at least true. 
A role of structure and storage in phenotypic stability 
is seen in our second example. In the case of ornithine and 
arginine, the pool sizes might threaten to overwhelm regula-
tory mechanisms and to encourage catabolic waste. Indeed, the 
structural mechanism by which these pools, presumably adaptive 
in their role, are segregated from the metabolic activities 
of the cytosol are just as significant as the more familiar 
phenomena of enzyme localization. By sequestering metabolites, 
eucaryotes can store large pools while retaining the sensitive 
control mechanisms we see in bacterial cytoplasm. 
If, as I have implied, these intracellular mechanisms are 
vital to the evolution and success of eucaryotes, one might 
ask what other possibilities might have arisen from primitive 
cornpartrnentation. First, membrane differentiation within 
cells was a necessary prelude to the development of more 
differentiated, more efficient, multicellular forms. Second, 
storage of reserves, even in acellular and unicellular forms, 
permits the organism to reallocate these reserves in hard 
times. The meiotic phase, supported by elaborate morphologi-
cal and physiological changes, is called for in many organisms 
in hard times. In fact, sex as we know it would not be pos-
sible without internalizing and protecting re~ources of the 
environment as the environment became depleted. 
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NOTE ADDED IN PROOF: 
Recent experiments in this laboratory by Dr. J. Cybis suggest, contrary 
to Figures 1 and 2, that the feedback-inhibitable enzyme of ornithine 
synthesis is in the cytoplasm, rather than in the mitochondria. This 
observation is consistent with the converse relation regarding CPSase A, 
a mitochondrial enzyme which is not feedback sensitive. 
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